388 a Phase Ib Trial in AD Patients Evaluating Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Formulations Containing the Kappa-Opioid Receptor Agonist WOL071-007

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.395
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search